Update in Cardiology
Authors: Kim A. Eagle
Journal: Annals of Internal Medicine (2000)

Updates from the Annual Session19 September 2000Update in CardiologyKim A. Eagle, MDKim A. Eagle, MDFrom University of Michigan Medical Center, Ann Arbor, Michigan.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-6-200009190-00012 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail From the wealth of information on cardiology published in the past year, I have chosen several important articles that cover coronary artery disease and congestive heart failure—the major clinical concerns of cardiologists today. This Update also evaluates research on risk factor modification and secondary prevention, along with competing strategies for managing both stable and unstable coronary artery disease. Finally, the roles of β-blockers, spironolactone, and diuretics in treating congestive heart failure and the place of home-based management are examined.Coronary Artery Disease: Primary PreventionRisks of Cigar Smoking and the Efficacy of Cigarette Smoking Interventions Were StudiedIribarren C, Tekawa IS, ...References1. Salo JA, Soisalon-Soininen S, Bondestam S, Mattila PS. Familial occurrence of abdominal aortic aneurysm. Ann Intern Med. 1999;130:637-42. LinkGoogle Scholar2. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ, et al . Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet. 1996;347:781-6. CrossrefMedlineGoogle Scholar3. . Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461-8. CrossrefMedlineGoogle Scholar4. . Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomised multicentre study. FRagmin and Fast Revascularisation during InStability in Coronary artery disease. Investigators. Lancet. 1999;354:701-7. CrossrefMedlineGoogle Scholar5. 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial. The Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group [Letter]. Lancet. 1998; 351:1180-1. Google Scholar Author, Article, and Disclosure InformationAuthors: Kim A. Eagle, MDAffiliations: From University of Michigan Medical Center, Ann Arbor, Michigan.Corresponding Author: Kim A. Eagle, MD, University of Michigan Medical Center, 3910 Taubman Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0366. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byReceptor-targeted Nanocomplexes optimized for Gene Transfer to Primary Vascular Cells and Explant Cultures of Rabbit Aorta 19 September 2000Volume 133, Issue 6Page: 439-446KeywordsAnginaAngioplastyCholesterolDiureticsHeart failureInfarctionLongitudinal studiesMyocardial infarctionRelative riskStable coronary artery disease ePublished: 19 September 2000 Issue Published: 19 September 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...